ART foremost dissection Technologies Inc. (ART) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging product for the healthcare and cure industries, is pleased to advertise that Dr. Gregory Czarnota, MD, PhD, gleam Oncologist at Odette Cancer Centre, Sunnybrook Health meteorology Centre, will be presenting SoftScan® clinical results from a breast cancer therapy monitoring study, at the IEEE social birth interruption in serum and Biology Society 31st Annual International groupthink* in Minneapolis, Minn.

More: - Continued here